Login / Signup
The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: are we there yet?
Shamir Geller
P L Myskowski
Y H Kim
A Moskowitz
S Horwitz
Published in:
The British journal of dermatology (2017)
Keyphrases
</>
hodgkin lymphoma
diffuse large b cell lymphoma
nk cells